Wednesday, January 4, 2012
SALT LAKE CITY, Jan. 4, 2012 (GLOBE NEWSWIRE)
-- LifeVantage Corporation (OTCBB:LFVN), maker of Protandim®, the
Nrf2 Synergizer™ patented dietary supplement, announced today that
Douglas C. Robinson, the Company's President and Chief Executive
Officer, will be presenting at the 14th Annual ICR XChange
Conference, to be held on January 11-12, 2012, at The Fontainebleau
Hotel in Miami Beach, Florida.
The LifeVantage investor presentation is scheduled for Thursday,
January 12, 2012, at 9:25 am Eastern Time. The presentation will be
webcast live and archived on the Investor Info portion of the
Company's website at
http://investor.lifevantage.com/events.cfm.
About ICR XChange
The ICR XChange is one of the largest and most unique investor
conferences of the year, and is open to institutional portfolio
managers and analysts, sell-side research analysts, investment
bankers from sponsoring firms only, private equity professionals,
select media and invited guests of ICR. The event is expected to
feature presentations by nearly 180 public and private companies,
as well as, a variety of discussion panels and keynote
presentations. Last year's attendance exceeded 1,500 institutional,
corporate and media attendees, and this January ICR is expecting
even greater participation. CNBC is also expected to broadcast live
at the event for the sixth consecutive year. For more information
on the conference, visit www.icrxchange.com.
About LifeVantage Corporation
LifeVantage, (OTCBB:LFVN), maker of Protandim®, the Nrf2
Synergizer™ patented dietary supplement, is a science based
nutraceutical company. LifeVantage is dedicated to visionary
science that promises to transform wellness and anti-aging
internally and externally with products that reduce oxidative
stress at the cellular level. The Company was founded in 2003 and
currently has operations in both Salt Lake City, Utah and San
Diego, CA. For more information, visit www.LifeVantage.com.
CONTACT: Investor Relations Contact:
Cindy England
(801) 432-9036
Director of
Investor Relations
-or-
John Mills
(310)-954-1105
Senior Managing
Director, ICR, LLC